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Background: Asthma and rhinitis are frequent respiratory diseases in children and adults.
Despite the increase in the aging population, there are few epidemiologic data on both dis-
eases in the elderly. So far, no population-based study has analyzed the association between
asthma and rhinitis symptoms and severity in this age group. This study aimed to estimate the
prevalence of physician-diagnosed asthma in the population aged 65 years in mainland
Portugal and to evaluate its association with the presence and classification of rhinitis accord-
ing to ARIA recommendations, in this age group.
Methods: A cross-sectional, nationwide, population-based survey of individuals aged 65
years, living in mainland Portugal was performed.
Results: Data were obtained from 3678 respondents. The prevalence of physician-diagnosed
asthma was 10.9% (95% confidence interval (95%CI) 9.9e11.9). The frequency of asthma diag-
nosis increased with the number of nasal symptoms (p < 0.001). A strong association between
asthma and rhinitis was found (odds ratio (OR) 13.86 (95%CI 10.66e18.02)). The strength of this
association increased with the persistence and severity of rhinitis, being particularly high in
elderly subjects with moderate-severe persistent rhinitis (OR 39.9 (95%CI 27.5e58.0)).munoallergy, Hospital CUF-Descobertas, Rua Ma´rio Botas, 1998-018 Lisbon, Portugal. Tel.: þ351
il.com (H. Pite).
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1118 H. Pite et al.Conclusions: Asthma is common in the elderly and strongly associated with rhinitis. The OR for
asthma is especially high in persistent and severe ARIA classification rhinitis types. This study
strengthens the need for an integrated assessment of asthma together with rhinitis in the
elderly.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Asthma and rhinitis are common and they are often asso-
ciated in children and adults [1e3]. Rhinitis is a risk factor
for asthma, being associated with increased severity and
health resource use in asthma. Therefore, international
guidelines consensually recommend that asthma and
rhinitis should be considered together [1,2].
In recent decades, a significant increase in the elderly
population has occurred, both in Europe and the U.S. This
increase in life expectancy joins a growing concern for
healthy, active aging. Epidemiological studies at the pop-
ulation level have been critical to the assessment of pop-
ulation’s needs with regard to chronic respiratory diseases
[3]. However, elderly-targeted, population-based studies
considering asthma and rhinitis are scarce [4e7], although
the greatest burden of asthma deaths has occurred among
elderly subjects [8,9].
We have recently estimated the prevalence of rhinitis in
the elderly population in Portugal and, for the first time,
rhinitis has been classified according to Allergic Rhinitis and
its Impact on Asthma (ARIA) recommendations in this age
group [6]. This study showed that rhinitis was a highly
prevalent but underdiagnosed and undertreated disease in
the elderly population, despite that over 40% had
moderate-severe disease. These data reinforced the need
to further explore the association between asthma and
rhinitis symptoms and severity in this age group, which, to
our knowledge, has not been addressed before in any
population-based study targeting the elderly.
Thus, we aimed to estimate the prevalence of physician-
diagnosed asthma (PDA) in the population aged 65 years in
mainland Portugal and to analyze its association with the
presence and classification of rhinitis according to ARIA
recommendations [2]. The secondary aim was to describe
socio-demographic characteristics associated with asthma
diagnosis and treatment, in this age group.Methods
Study design and participants
Population-based, cross-sectional survey applied by face-
to-face interview to individuals aged 65 years, living in
mainland Portugal.
The study’s methodology has been previously detailed
[6]. Briefly, a stratified (by gender, age and region),
multistep sampling strategy was used. The estimation of
the number of needed participants was based on the data
from the 2001 Portuguese Census on individuals aged 65
years, considering all five regions of mainland Portugal [10].The selection criteria of municipalities within each Portu-
guese region corresponded to the aging index, population
density and purchasing power, indicators that summarize
the main regional social disparities [10]. The final selection
was done by random-route methodology, where households
and nursing homes from the selected municipalities were
included. This sampling strategy allowed for a representa-
tive sample of the mainland Portuguese population aged
65 years, regarding the factors used for sample stratifi-
cation [6].
Informed consent was obtained from all participants.
This study’s protocol was reviewed and approved by the
Ethics Committee of CUF-Descobertas Hospital, Lisbon,
Portugal.
Instruments and data collection
The instrument for data collection has been previously
published [6]. The questions on PDA and physician-
diagnosed asthma on current treatment (PDA/CT) were
based on the European Community Respiratory Health
Survey (ECRHS) [11].
Rhinitis severity was assessed using a 0e10 visual
analogue scale (VAS), as previously suggested [12].
Questionnaires were applied by trained interviewers
between May and July 2008. Inter-interviewer variability in
the results was controlled by standardized training and
interview framework, which application was monitored by
a supervisor.
Definitions
Definitions used in this study are presented in Table 1. In
individuals with rhinitis, it was further classified into
intermittent/persistent and mild/moderate-severe, ac-
cording to current ARIA guidelines [2] (Table 1).
Socio-demographic characteristics included gender
(“male” or “female”) and age (in years); municipality was
considered as “urban” or “rural”, according to living mu-
nicipality typology [10], and residency was categorized as
living in “own house” (i.e., home ownership), living “with
relatives” (i.e., in family members’ home ownership) or in
“nursing home” (i.e., home for the elderly).
Sample size and statistical analysis
The primary endpoint of the study was rhinitis prevalence
[6]. Considering that the prevalence of asthma in the
elderly is estimated to be around 8% [13], the inclusion of
3500 subjects (computed based on rhinitis endpoints) al-
lows the estimation of asthma prevalence with an error of
0.9% (precision) in 95% confidence interval (95%CI).
Table 1 Definitions used in this study.
Variable Source Definition
Physician-diagnosed asthma (PDA) Adapted from ECRHS [11] Positive answer to the question “Has a doctor
ever said you have asthma?”.
Physician-diagnosed asthma on
current treatment (PDA/CT)
Adapted from ECRHS [11] Presence of physician-diagnosed asthma and
a positive answer to the question “Do you
take medication for asthma?”.
Current rhinitis Based on ECRHS and ARIA [2,11,43] Presence, usually or in the last 12 months, of
at least two of the following symptoms:
“repeated sneezing and itchy nose”; “blocked
nose for more than one whole hour” or “runny
nose when not having a cold or flu”.
Intermittent rhinitis Built according to ARIA [2] Current rhinitis with nasal symptoms lasting less
than 4 days in a week or lasting more than
4 days/week but less than 4 consecutive weeks.
Persistent rhinitis Built according to ARIA [2] Current rhinitis with nasal symptoms lasting for
at least 4 days in a week and for more than
4 consecutive weeks.
Mild rhinitis Adapted from Bousquet et al. [12] Current rhinitis that had a visual analogue
scale severity score ranging between 0 and 5.
Moderate-severe rhinitis Adapted from Bousquet et al. [12] Current rhinitis that had a visual analogue
scale severity score ranging between 6 and 10.
Rhinoconjunctivitis Adapted from ECRHS [11] Presence of rhinitis and a positive answer to
the question “Do nasal symptoms usually
occur along with red or itchy-watery eyes?”.
Physician-diagnosed rhinitis Additional question [43] Positive answer to the question “Has a doctor
ever said you have rhinitis?”.
Current rhinitis treatment Adapted from ECRHS [11] Positive answer to the question “Have you had
any medication for rhinitis (nasal topical drug
or pill) in the last 12 months?”.
Asthma and rhinitis in the elderly 1119Categorical variables were described using absolute and
relative frequencies with 95%CI; comparisons were per-
formed using the Pearson’s chi-square test and linear by
linear association. Continuous variables were described
with mean and standard deviation (SD); comparisons were
performed using an independent samples t-test, or WelchTable 2 Socio-demographic characteristics of the participant
status.
Total (n Z 3678)
n (%)
Gender
Female 2151 (58.5)
Age, years
65e74 2128 (57.9)
75e84 1204 (32.7)
85 346 (9.4)
Municipality
Urban 2752 (76.5)
Rural 845 (23.5)
Residency
Own house 2657 (73.2)
With relatives 632 (17.4)
Nursing home 343 (9.4)test if equality of variances was not assumed. A significance
level of 5% was considered.
Univariate logistic regression models for “PDA” and
“PDA/CT” were developed using independent variables as
risk/predictive factors. Gender, age group, municipality
typology and residency were considered as possible risks, including stratification by “physician-diagnosed asthma”
Physician-diagnosed asthma
Yes (n Z 401)
n (%)
No (n Z 3274)
n (%)
254 (63.3) 1896 (57.9)
232 (57.9) 1896 (57.9)
126 (31.4) 1077 (32.9)
43 (10.7) 301 (9.2)
288 (71.8) 2461 (75.2)
107 (26.7) 738 (22.5)
254 (63.3) 2400 (73.3)
81 (20.2) 551 (16.8)
64 (16.0) 279 (8.5)
Table 3 Prevalence of physician-diagnosed asthma and physician-diagnosed asthma on current treatment and logistic regression models with crude and adjusted odds ratio
(OR) with 95% confidence intervals (95%CI).
Physician-diagnosed asthma Physician-diagnosed asthma on current treatment
Prevalence Crude Adjusted Prevalence Crude Adjusted
% (95%CI) OR (95%CI) OR (95%CI) % (95%CI) OR (95%CI) OR (95%CI)
Whole sample 10.9 (9.9e11.9) 7.6 (6.7e8.4)
Gender 0.037* 0.097* 0.046* 0.162*
Female 11.8 (10.5e13.3) 1.00 1.00 8.3 (7.1e9.5) 1.00 1.00
Male 9.6 (8.3e11.4) 0.80 (0.64e0.99) 0.83 (0.67e1.03) 6.6 (5.4e7.9) 0.77 (0.60e1.00) 0.83 (0.64e1.08)
Age, years 0.569* NI 0.531* NI
65e74 10.9 (9.8e12.5) 1.00 7.6 (6.5e8.7) 1.00
75e84 10.5 (8.7e12.3) 0.96 (0.76e1.20) 7.1 (5.7e8.6) 0.93 (0.71e1.23)
85 12.4 (9.0e16.1) 1.17 (0.83e1.65) 9.0 (6.0e12.0) 1.19 (0.80e1.79)
Municipality 0.076* 0.102* 0.214* 0.299*
Urban 10.5 (9.4e11.7) 1.00 1.00 7.3 (6.3e8.3) 1.00 1.00
Rural 12.7 (10.5e15.1) 1.24 (0.98e1.57) 1.22 (0.96e1.55) 8.6 (6.7e10.5) 1.19 (0.90e1.58) 1.16 (0.88e1.54)
Residency <0.001* <0.001* <0.001* <0.001*
Own house 9.6 (8.5e10.8) 1.00 1.00 6.2 (5.3e7.1) 1.00 1.00
With relatives 12.8 (10.2e15.5) 1.39 (1.06e1.81) 1.36 (1.04e1.78) 10.1 (7.6e12.5) 1.71 (1.27e2.32) 1.66 (1.23e2.26)
Nursing home 18.7 (14.2e22.6) 2.17 (1.60e2.93) 2.06 (1.51e2.79) 14.3 (10.6e18.0) 2.53 (1.80e3.56) 2.37 (1.67e3.35)
Current rhinitis <0.001* NI <0.001* NI
No 2.9 (2.3e3.6) 1.00 2.1 (1.6e2.7) 1.00
Yes 29.6 (27.0e32.4) 13.86 (10.66e18.02) 20.5 (18.1e22.9) 12.08 (8.88e16.41)
Rhinoconjunctivitis <0.001* NI <0.001* NI
No 4.3 (3.6e5.1) 1.00 2.7 (2.1e3.3) 1.00
Yes 36.4 (32.9e39.8) 22.15 (17.53e27.98) 26.6 (23.4e29.8) 16.92 (12.36e23.18)
Physician-diagnosed rhinitis <0.001* NI <0.001* NI
No 7.4 (6.6e8.5) 1.00 5.3 (4.5e6.1) 1.00
Yes 34.1 (30.1e38.7) 6.46 (5.13e8.13) 23.1 (19.3e26.9) 5.40 (4.15e7.03)
Current rhinitis treatment <0.001* NI <0.001* NI
No 7.6 (6.7e8.5) 1.00 5.5 (4.7e6.3) 1.00
Yes 32.8 (28.6e37.0) 5.96 (4.74e7.51) NI 21.5 (17.9e25.1) 4.75 (3.65e6.19) NI
* p-value; OR, odds ratio; 95%CI, 95% confidence interval; NI, Not included.
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Figure 1 Prevalence of physician-diagnosed asthma in rela-
tion to nasal and ocular symptoms.
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diagnosed rhinitis, current rhinitis treatment and rhinitis
classification categories as possible predictive factors
(frequently associated pathologies that may share common
risk factors). Multivariate logistic regression models were
developed for “PDA” and “PDA/CT”. Only possible risk
factors were included in the multivariate logistic regression
models; they were chosen according to the p-value of the
univariate analysis, considering a cut-off of <0.250. The
HosmereLemeshow test was used to assess calibration of
the multivariate models; a p > 0.05 was deemed necessary
to consider that the model was calibrated. Results of both
univariate and multivariate logistic regression models were
presented as odds ratio (OR) with 95%CI.
Data analyses were performed using SPSS version 19.0
for Windows (IBM SPSS, Chicago, IL, USA).
Results
Participants’ characteristics
A total of 3699 out of 4000 invited subjects answered the
questionnaire (response rate 92.5%). There was no evi-
dence of different response rates according to age. From
the answered questionnaires, 21 were excluded: 13 sub-
jects were aged less than 65 years old and eight had
insufficient information due to incomplete interviews. Data
was obtained from 3678 responders. Participants’ socio-
demographic characteristics are summarized in Table 2.
Prevalence of physician-diagnosed asthma and
physician-diagnosed asthma on current treatment
The prevalence of PDA was 10.9% (95%CI 9.9%e11.9%).
Seventy per cent of the elder subjects with asthmaTable 4 Comparison of elderly subjects with physician-diagnos
Physician-diagnosed a
On current treatment
[n Z 279]
n (%)
Gender
Female 179 (64.2)
Age, years
65e74 162 (58.1)
75e84 86 (30.8)
85 31 (11.1)
Municipality
Urban 202 (72.4)
Rural 73 (26.2)
Residency
Own house 164 (58.8)
With relatives 64 (22.9)
Nursing home 49 (17.6)
Current rhinitis 225 (80.6)
Rhinoconjunctivitis 200 (71.7)
Physician-diagnosed rhinitis 111 (39.8)
Current rhinitis treatment 105 (37.6)reported to be under current asthma treatment. The
prevalence of PDA/CT was 7.6% (95%CI 6.7%e8.4%).
The prevalence of PDA was lower in men compared to
women (9.6% vs 11.8%, p Z 0.037). No statistically signifi-
cant differences were found in the prevalence of asthma
according to the age group or between urban and rural
municipalities (Table 3). Adjusting for other independent
variables, living with relatives and, especially, living in a
nursing home, when compared with living in their own
house, was significantly and positively associated with PDA
and PDA/CT (Table 3). In the multivariate analysis, there
was no significant effect of gender on both outcomes (Table
3). Table 4 shows the comparison of elderly subjects with
PDA according to asthma treatment. Elderly subjects with
PDA living in their own house had current asthma treatment
less frequently (Table 4).ed asthma, with and without current asthma treatment.
sthma [n Z 401] p-Value
No current treatment
[n Z 122]
n (%)
0.608
75 (61.5)
0.887
70 (57.4)
40 (32.8)
12 (9.8)
0.881
86 (70.5)
34 (27.9)
0.020
90 (73.8)
17 (13.9)
15 (12.3)
100 (82.0) 0.756
72 (59.0) 0.013
53 (43.4) 0.493
53 (43.4) 0.221
Table 5 Prevalence of physician-diagnosed asthma and physician-diagnosed asthma on current treatment according to ARIA
rhinitis classification categories.
Physician-diagnosed asthma Physician-diagnosed asthma on current treatment
% (95%CI) % (95%CI)
Mild intermittent rhinitis <0.0001* <0.0001*
No 9.2 (8.2e10.2) 6.6 (5.7e7.5)
Yes 20.2 (16.8e23.6) 13.0 (10.1e15.9)
Moderate-severe intermittent rhinitis <0.0001* <0.0001*
No 9.1 (8.1e10.1) 6.2 (5.4e7.0)
Yes 30.6 (25.4e35.8) 23.2 (18.4e28.0)
Mild persistent rhinitis <0.0001* <0.0001*
No 10.4 (9.4e11.4) 7.2 (6.4e8.0)
Yes 33.3 (22.6e44.0) 24.0 (14.3e33.7)
Moderate-severe persistent rhinitis <0.0001* <0.0001*
No 8.6 (7.7e9.5) 6.0 (5.2e6.8)
Yes 54.8 (47.5e62.1) 37.3 (30.2e44.4)
* p-value; 95%CI, 95% confidence interval.
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1122 H. Pite et al.Association between asthma and rhinitis
Of subjects with PDA, 81.1% had current rhinitis, 68.3%
rhinoconjunctivitis and 40.9% reported to have physician-
diagnosed rhinitis. Current rhinitis was found in 80.7% of
patients with PDA/CT, of whom 46.7% had physician-
diagnosed rhinitis and 43.6% were on current rhinitis
treatment. On the other hand, PDA was reported by 29.6%
subjects with current rhinitis, 36.4% with rhinoconjuncti-
vitis and 34.1% with physician-diagnosed rhinitis. In uni-
variate analysis, all three conditions were strongly
associated with PDA and PDA/CT, particularly current
rhinitis and rhinoconjunctivitis (Table 3). The frequency of
rhinoconjunctivitis was higher in subjects with PDA/CT,
compared to those without asthma treatment (Table 4).
The prevalence of PDA increased with the number of
rhinitis symptoms, from 2.1% in no rhinitis symptoms to(VAS – visual analogue scale, cm)
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Figure 2 Cumulative relative frequency distribution of
rhinitis severity visual analogue scale score in elderly subjects,
according to the presence of physician-diagnosed asthma and
physician-diagnosed asthma on current treatment.39.3% in three nasal complaints and 44.4% in nasal symp-
toms combined with ocular symptoms; p < 0.0001 by linear-
by-linear association (Fig. 1).
Risk for asthma according to ARIA rhinitis
classification
The prevalence of PDA and PDA/CT according to the ARIA
classification of rhinitis is presented in Table 5. The(OR – odds ratio; 95%CI – 95% confidence interval)
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Figure 3 Odds ratio with 95% confidence interval for
physician-diagnosed asthma (A) and physician-diagnosed
asthma on current treatment (B) according to ARIA rhinitis
classification categories.
Asthma and rhinitis in the elderly 1123association between PDA and current rhinitis was evident in
all rhinitis classes.
Figure 2 shows the cumulative relative frequency dis-
tribution of rhinitis severity VAS score, according to the
presence of PDA and PDA/CT. Rhinitis severity VAS scores
were significantly higher in elderly subjects with PDA
(5.7 cm SD 2.1 vs. 4.6 cm SD 2.3 in those without asthma,
Welch test p < 0.001) and with PDA/CT (5.8 cm SD 2.0 vs.
4.6 cm SD 2.3 in those without asthma, Welch test
p < 0.001).
The OR for asthma increased with increased frequency
and severity of rhinitis symptoms, and was strongest in
subjects with moderate-severe persistent rhinitis (Fig. 3A).
Having current rhinitis was also significantly associated with
PDA/CT; this relation was present in all rhinitis classes,
especially in subjects with moderate-severe persistent
rhinitis (Table 5; Fig. 3B).Discussion
A high prevalence of self-reported PDA was found in the
Portuguese population aged 65 years (10.9%; IC95%
9.9e11.9). This study showed a strong association between
rhinitis, rhinoconjunctivitis and asthma diagnosis in this age
group. The strength of the association between asthma and
rhinitis increased with longer persistence and higher
severity of rhinitis symptoms, considering the ARIA rhinitis
classification.
This study was the first nationwide population-based
epidemiological study exclusively dedicated to the elderly
that concurrently evaluated asthma and rhinitis symptoms
and ARIA classification and that reported a relation between
asthma and rhinitis severity/duration, in this age group. It
included a large representative sample of elderly subjects,
allowing the estimation of PDA prevalence in mainland
Portugal and the characterization of its association with
rhinitis according to ARIA recommendations.
The study’s main limitations are due to its cross-sectional
design, the absence of physician confirmation/evaluation,
lung function parameters and in vivo and/or in vitro atopy
markers, and the lack of information regarding environ-
mental exposures (namely tobacco smoke), lower respira-
tory symptoms, asthma severity and control. Other factors,
such as recall or information biases may have influenced the
results. Nevertheless, the use of a short and simple ques-
tionnaire, applied by trained interviewers, facilitated the
inclusion of the elderly subjects. It also minimized diffi-
culties in reading or comprehending and the loss of compli-
ance throughout the interview, allowing for very fewmissing
data regarding all variables [6].
A recent study, the Portuguese National Asthma Survey,
estimated that the prevalence of current asthma (i.e., with
symptoms in the last 12 months) in Portugal was 6.8% (95%CI
6.0e7.7) [13]. In this study, the subgroup analysis by age
groups showed no statistically significant difference in the
prevalence of current asthma in individuals aged 65 years.
However, adjusting for possible confounding factors, the
prevalence of asthma was lower in elderly subjects who
reported no heart disease. Since heart disease is common in
the elderly and may be a cause of respiratory symptoms,
the authors pointed out the possibility of an overestimationof current asthma in elderly subjects with cardiac disease.
Asthma prevalence estimates did not change after adjust-
ing for chronic bronchitis [13].
In the present study, in spite of the limitations due to
PDA being only self-reported and the lack of information on
environmental exposures including tobacco smoke, the fact
that a doctor’s diagnosis and current asthma treatment
were considered may have helped to reduce bias and con-
founding factors related to respiratory symptoms caused by
other conditions, such as heart disease, bronchitis or
chronic obstructive pulmonary disease (COPD). Nonethe-
less, distinguishing asthma from COPD can be particularly
difficult. COPD is often assumed to be an “aging-related
disease”, remaining an important comorbidity leading
physicians to diagnose COPD rather than asthma in the
elderly [14e16]. Conversely, other studies report asthma
overdiagnosis in adults, including COPD misdiagnosis with
asthma [17e19].
Considering the prevalence of PDA/CT as a proxy for
“active asthma”, we found that 7.6% (95%CI 6.7e8.4%) of
the Portuguese elderly population had an active disease.
Despite the lack of information on asthma control, this does
not differ significantly from the estimated prevalence of
current asthma in elderly in the study mentioned above
(8.0% (95%CI 6.7e9.5)) [13], suggesting that this might be
an accurate approximation of the real prevalence in the
Portuguese population. In other epidemiological studies
targeting elderly subjects from other countries, the prev-
alence of asthma varied between 3.6% and 7.6%
[4,5,7,20e27]. However, the different selection criteria
and definitions of asthma limit inter-studies comparisons.
Asthma overdiagnosis or other stated biases may have
concurred for the higher prevalence obtained in this study.
A study including medical evaluation, information on to-
bacco and other environmental exposures, and lung func-
tion parameters would be of utmost importance to address
this issue in the elderly.
In this study we noted that, as for rhinitis [6], after
adjusting for independent variables, the diagnosis of
asthma was associated with living with relatives and espe-
cially living in a nursing home. This may suggest that these
elderly subjects, compared to those who reside in their own
house, have greater frequency of asthma or better access
to medical care. The fact that those individuals living in
their own house had current asthma treatment less
frequently may either reflect better asthma control in this
group, or, on the contrary, support the assumption
regarding worse access to medical care in elderly subjects
living in their own house. Yet, it should also be considered
that those elderly living in nursing homes often have
greater deconditioning or multiple co-morbidities that may
mimic asthma, which could contribute for misdiagnosis of
this disease.
In accordance with the Portuguese National Asthma
Survey [13], in multivariate analysis, asthma prevalence
was similar in both genders and according to municipality
typology. Unlike suggested by other studies [15,20], the
prevalence of asthma in the elderly did not diminish with
age. However, this could also reflect an increasing ten-
dency for asthma misclassification with COPD or other
mimicking conditions, with increasing age [17e19], which
should be explored.
1124 H. Pite et al.The present study, including only older adults, also
showed a strong association between rhinitis, rhino-
conjunctivitis and self-reported asthma diagnosis. About
80% of elderly subjects diagnosed with asthma had rhinitis;
among elderly subjects with rhinitis, 30% had asthma
diagnosed by a doctor. The prevalence of asthma diagnosis
increased with the number of nasal symptoms, especially
when they were associated with ocular symptoms. These
results support an extensive noseelung interaction also in
the elderly, which has been observed by others [28e31].
Furthermore, considering the difficulties in distinguishing
asthma from other relevant conditions in differential
diagnosis, our data may more broadly indicate that there
might also be a relationship between rhinitis and other
diseases responsible for lower respiratory symptoms in the
elderly, namely COPD. Other studies strengthen the fact
that the “united airways” concept goes beyond the scope of
asthma and also support an association between rhinitis
and COPD [32e34].
The definition for current rhinitis used in this study,
requiring the presence of at least two nasal symptoms, sug-
gests the diagnosis of allergic rhinitis. This is reinforced in
the elderly with concomitant complaints of red eye, eye
pruritus or epiphora, suggesting allergic rhinoconjunctivitis.
The fact that the association between rhinitis and asthma
has been particularly notable in elderly patients with rhi-
noconjunctivitis may suggest an increased risk of asthma
when there is greater likelihood of involvement of allergic
mechanisms. Rhinoconjunctivitis was more frequent in
elderly subjects with PDA/CT, compared to those without
asthma treatment, which may suggest a possible relation
with atopy. However, the definitions of allergic rhinitis and
allergic rhinoconjunctivitis were not used because they
require the assessment of the specific immunological
mechanisms involved and that was not part of this study.
This report further emphasizes that rhinitis in the elderly
is underdiagnosed andundertreated [6]. About 40% of elderly
patientswith PDA had complaints of current rhinitis butwere
not diagnosed or treated for rhinitis. This is reinforced in
those on current treatment for asthma and concurrent cur-
rent rhinitis, where more than half of these patients had no
physician diagnosis of rhinitis. Considering that rhinitis
symptoms and lack of control interfere with asthma [1,2],
there should be a greater awareness for the assessment of
nasal disease in patients with an asthma diagnosis.
The strong association found between asthma, asthma
on current treatment and all ARIA classes of rhinitis further
supports the importance of an accurate rhinitis diagnosis in
the elderly, including in milder presentations. The ARIA
classification of rhinitis provided important information
with regard to the strength of the association with asthma,
as it increased with increased persistency and severity of
rhinitis. While contradicting some previous studies [35e37],
moderate-severe persistent rhinitis had an especially strong
association with asthma, as also reported by other authors,
in different age groups [2,38e42].
Addressing respiratory diseases in the elderly, including
asthma and rhinitis, is a recognized imperative need [1e3],
especially when taking into account their impact and the
trend for an increase in the elderly population in many
countries worldwide. This study showed that asthma is
prevalent in the elderly, being strongly associated withrhinitis and rhinoconjunctivitis. The strength of this asso-
ciation increases very significantly with longer persistence
and higher severity of rhinitis. This study highlights the
need for a clinical integrated, global assessment of asthma
together with rhinitis in this age group and may contribute
to the designing of future studies addressing both diseases
in the elderly.
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